Carazolol is a high-affinity beta-adrenergic receptor antagonist primarily utilized in veterinary medicine to reduce stress and mitigate cardiovascular responses in livestock during transport or handling.… Read more
Carazolol is a high-affinity beta-adrenergic receptor antagonist primarily utilized in veterinary medicine to reduce stress and mitigate cardiovascular responses in livestock during transport or handling. As a potent beta-blocker, it serves as a critical subject in pharmacological research and quality control, where analytical laboratories rely on high-quality materials for precise testing. This category includes racemic carazolol along with related analytical markers, such as nitroso impurities, which are essential for rigorous impurity profiling and safety assessments during stability testing. Additionally, stable isotope labelled compounds and deuterated standards are provided to facilitate accurate quantification and metabolic tracing in complex matrices. These reference standards enable laboratories to perform comprehensive method validation and ensure compliance with regulatory standards, supporting the development of reliable analytical protocols for monitoring this compound and its potential degradation products in pharmaceutical and veterinary applications.